Clinical Trial

Fontan Outcomes in Oligemia vs Plethora in Univentricular CHD

Recruiting
View on ClinicalTrials.gov →
Summary
This prospective cohort study evaluates differences in clinical outcomes between pulmonary oligemia and pulmonary plethora in patients with cyanotic congenital heart disease and univentricular heart physiology undergoing staged palliation culminating in the Fontan procedure.Fifty-two patients will be classified into two groups based on pulmonary blood flow characteristics and followed for approximately 1.5 years after the Fontan procedure. Outcomes include mortality, morbidity, pulmonary hemodynamics, functional capacity, neurocognitive status, and quality of life.
Trial Details
NCT Number NCT07535203
Lead Sponsor Sisca Natalia Siagian
Collaborators: LMU Klinikum, Fakultas Kedokteran Universitas Indonesia, National Cardiovascular Center Harapan Kita Hospital Indonesia
Conditions Congenital Heart Disease (CHD), Univentricular Heart
Enrollment 52 participants
Start Date 2025-01-01
Primary Completion 2027-03-01 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-17